An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas (Q84840694)
Jump to navigation
Jump to search
scientific article published on 21 August 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas |
scientific article published on 21 August 2012 |
Statements
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas (English)
M Agulnik
J L Yarber
S H Okuno
M von Mehren
B D Jovanovic
B E Brockstein
R S Benjamin
21 August 2012